Meeder Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Meeder Asset Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,619	Closed	-$92K	–	2563
2021 Q3	$92K	Buy	4,619 +2,279	+97%	+$62.9K	﹤0.01%	922
2021 Q2	$87K	Sell	2,340 -557	-19%	-$17.1K	﹤0.01%	942
2021 Q1	$74K	Buy	+2,897	New	+$74K	﹤0.01%	989
2020 Q4	–	Sell	-7,024	Closed	-$125K	–	2375
2020 Q3	$125K	Buy	+7,024	New	+$145K	0.01%	723
2020 Q2	–	Sell	-1,808	Closed	-$33K	–	2647
2020 Q1	$33K	Sell	1,808 -4,182	-70%	-$81.3K	﹤0.01%	1061
2019 Q4	$131K	Buy	+5,990	New	+$121K	0.01%	724
2019 Q3	–	Sell	-613	Closed	-$10K	–	2320
2019 Q2	$10K	Hold	613	–	–	﹤0.01%	1467
2019 Q1	$9K	Sell	613 -552	-47%	-$6.34K	﹤0.01%	1283
2018 Q4	$12K	Buy	1,165 +90	+8%	+$1.18K	﹤0.01%	1210
2018 Q3	$17K	Buy	+1,075	New	+$15.6K	﹤0.01%	1071

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Meeder Asset Management's DRNA Position: Q4 2021 in Review

Meeder Asset Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 4,619 shares — an estimated $92K sold.

Meeder Asset Management first reported a position in DRNA in Q3 2018 and held it in 10 quarters. The position peaked at $131K in Q4 2019. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Meeder Asset Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Meeder Asset Management sold 4,619 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $92K.
Meeder Asset Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2018 and held it in 10 quarters.
Meeder Asset Management's Dicerna Pharmaceuticals, Inc. position peaked at $131K in Q4 2019.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.